Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Henry Schein    HSIC

HENRY SCHEIN (HSIC)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Henry Schein : Acquires eVetPractice, A Cloud-Based Veterinary Clinic Practice Management Solutions Company

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/18/2017 | 02:20pm CET

MELVILLE, N.Y., Dec. 18, 2017 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that it has acquired eVetPractice, a leading provider of cloud-based practice management solutions to veterinary clinics. eVetPractice will join Henry Schein Veterinary Solutions (HSVS), the global leader in veterinary technology solutions, and become the newest addition to its expanding software portfolio.

'As the veterinary practice management software market expands into cloud-based solutions, we at Henry Schein understand that partnering with eVetPractice enhances our ability to power successful practices by providing our customers with the latest in value-added services and technology solutions,' said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. 'Our distribution footprint and comprehensive technology offerings, which now includes the cloud, ensure that veterinary professionals can continue to rely on us as a trusted advisor, as we endeavor to help them operate more efficient and successful practices while delivering quality care.'

Based in Athens, Georgia, and founded in 2011, eVetPractice is one of the fastest-growing cloud solutions in the U.S., serving approximately 900 customers. Henry Schein expects this transaction to be neutral to its 2018 earnings per share and to be accretive thereafter. Additional financial details and terms were not disclosed.

'eVetPractice will become an integrated part of Henry Schein's portfolio of technology solutions, which includes AVImark and ImproMed in North America, as well as Vision, RxWorks, and RoboVet internationally,' said Chris Dollar, Global President of Henry Schein Veterinary Solutions. 'The highly regarded eVetPractice solution will complement these offerings for our current and prospective customers who prefer the benefits of a cloud solution.'

eVetPractice was founded by Eddie Heinz, who will join the HSVS executive team and continue to lead the eVetPractice solution and customer support teams. 'Henry Schein's excellent reputation and extensive reach among veterinarians bodes well for our continued success and we are excited to become a part of this team,' said Mr. Heinz. 'In 2018, the eVetPractice software will be offered to current Henry Schein Veterinary Solutions customers as an option to move to the cloud. We will integrate the HSVS solutions into the eVetPractice software to bring those market-leading solutions to current and future eVetPractice customers.'

Henry Schein Veterinary Solutions, which has North American offices in Oshkosh, Wisconsin, Piedmont, Missouri, and Trevose, Pennsylvania, is the leading global veterinarian practice management software developer. Henry Schein Animal Health is based in Dublin, Ohio, and is the leading companion animal health distribution company in the United States, employing approximately 1,000 team members, including more than 250 field sales representatives and 150 telesales and customer support representatives. With 13 strategically located, state-of-the-art distribution facilities and seven inside sales centers, the company maintains a greater than 99 percent order-fill ratio, in line with its mission to provide the best customer experience possible.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional healthcare clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein employs more than 22,000 Team Schein Members and serves more than 1 million customers.

The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. The company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 34 countries. The company's sales reached a record $11.6 billionin 2016, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the 'Safe Harbor' provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as 'may,' 'could,' 'expect,' 'intend,' 'believe,' 'plan,' 'estimate,' 'forecast,' 'project,' 'anticipate' or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive and consolidating market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic conditions; risks associated with currency fluctuations; risks associated with political and economic uncertainty; disruptions in financial markets; volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; increased competition by third party online commerce sites; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.

View original content:http://www.prnewswire.com/news-releases/henry-schein-acquires-evetpractice-a-cloud-based-veterinary-clinic-practice-management-solutions-company-300572383.html

SOURCE Henry Schein, Inc.

Investors, Steven Paladino, Executive Vice President and Chief Financial Officer, [email protected], (631) 843-5500 or Carolynne Borders, Vice President, Investor Relations, [email protected], (631) 390-8105; Media, Ann Marie Gothard, Vice President, Corporate Media Relations, [email protected], (631) 390-8169

Henry Schein Inc. published this content on 18 December 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 December 2017 13:19:10 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HENRY SCHEIN
02:20p HENRY SCHEIN : Acquires eVetPractice, A Cloud-Based Veterinary Clinic Practice M..
12/14 HENRY SCHEIN : Celebrates The Season With Its 19th Annual Holiday Cheer For Chil..
12/11 HENRY SCHEIN : Disaster Relief Hotline Open for Customers Affected by Southern C..
12/08 HENRY SCHEIN : Disaster Relief Hotline Is Open To Support Customers Affected By ..
12/08 Henry Schein, Inc. (HSIC) Shares Bought by Skandinaviska Enskilda Banken AB p..
11/21 HENRY SCHEIN : To Present At The Nasdaq 37th Investor Conference
11/16 HENRY SCHEIN : AADOM Presents Fifth Annual Green Leader Award To Surf City Denta..
11/16 HENRY SCHEIN : To Showcase Digital Solutions At Greater New York Dental Meeting,..
11/09 HENRY SCHEIN : Earns Top Marks In 2018 Corporate Equality Index
11/09 HENRY SCHEIN : AADOM Presents Fifth Annual Green Leader Award To Surf City Denta..
More news
News from SeekingAlpha
09:43a Henry Schein buys vet practice management software provider
12/06 Morgan Stanley bearish on Patterson and Schein by Amazon threat
11/28 Premarket analyst action - healthcare
11/27 Henry Schein Now Inexpensive After 20% Drop
11/25 Tracking Al Gore's Generation Investment Management Portfolio - Q3 2017 Updat..
Financials ($)
Sales 2017 12 439 M
EBIT 2017 854 M
Net income 2017 561 M
Debt 2017 1 360 M
Yield 2017 -
P/E ratio 2017 19,82
P/E ratio 2018 17,95
EV / Sales 2017 0,99x
EV / Sales 2018 0,92x
Capitalization 11 012 M
Chart HENRY SCHEIN
Duration : Period :
Henry Schein Technical Analysis Chart | HSIC | US8064071025 | 4-Traders
Technical analysis trends HENRY SCHEIN
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 81,0 $
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski President & Director
Steven Paladino Chief Financial Officer, Director & Executive VP
James A. Harding Chief Technology Officer & Senior Vice President
Philip A. Laskawy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN-7.51%11 012
COLOPLAST A/S1.51%15 112
CANTEL MEDICAL CORP.26.43%4 162
PATTERSON COMPANIES, INC.-11.04%3 493
AMPLIFON SPA37.79%3 316
MERIT MEDICAL SYSTEMS, INC.69.43%2 254